Evidence map›Paper›PMID 42049255›Full record

ArticleInternational journal of STD & AIDS2026

Chemsex-associated drug use amongst men and gender-diverse people having sex with men in the UK: Findings from an online community survey, 2024.

George Baldry, Giulia Habib Meriggi, Dolores Mullen, Helen Corkin, Amelia Andrews, Catherine M Lowndes, David Reid, Catherine H Mercer, John Saunders, Hamish Mohammed and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of STD & AIDS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

George BaldryBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.ORCID 0009-0009-9292-1379
Giulia Habib MeriggiBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.ORCID 0009-0006-4820-4493
Dolores MullenBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
Helen CorkinBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
Amelia AndrewsBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
Catherine M LowndesBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
David ReidInstitute for Global Health, University College London, London, UK.
Catherine H MercerInstitute for Global Health, University College London, London, UK.
John SaundersBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.ORCID 0000-0003-3020-9916
Hamish MohammedBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.
Dana OgazBlood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectivesChemsex is the use of select psychoactive drugs to enhance sexual experiences and has been described among gay, bisexual, and other men who have sex with men (GBMSM). We aimed to characterise sexual risk, wellbeing and health-seeking behaviours among GBMSM and gender-diverse people reporting chemsex-associated drug use.MethodsWe analysed data from 'Reducing inequalities in Sexual Health' (RiiSH), an online community survey of 2758 UK-resident men and gender-diverse people having sex with men undertaken in November-December 2024. We compared those reporting chemsex-associated drug use with those who did not, assessing sociodemographic characteristics, well-being, sexual risk behaviours and sexual health service (SHS) engagement.ResultsOverall, 8% (218/2758) reported chemsex-associated drug use in the last year. A higher proportion of participants reporting chemsex-associated drug use in the last year also reported a composite measure of sexual risk based on self-reported behaviours in the previous 3-4 months (e.g. prior bacterial STI diagnosis, ≥5 male condomless anal sex partners) compared to those who did not (85% vs 61%,

Indexed as

ChemsexHomosexuality, MaleSexual and Gender MinoritiesSexual BehaviorSubstance-Related DisordersAdolescentAdultGender-Nonconforming PersonsHumansMaleMiddle AgedRisk-TakingSexual HealthSexual PartnersSurveys and QuestionnairesUnited Kingdomchemsexdrug useGBMSMsexual healthUnited Kingdom

Identifiers

PMID42049255
PMCPMC13279977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.